Bóng phủ thuốc: Tiếp cận mới trong điều trị tái hẹp lại trong Stent
Tóm tắt
Bóng phủ thuốc: Tiếp cận mới trong điều trị tái hẹp lại trong StentTài liệu tham khảo
1. King SB, Schlumpf M. Ten year completed follow-up of percutaneous transluminal coronary angioplasty: the early Zurich experiance. J Am Coll Cardiol 1993; 22: 353-360.
2. Sigwart U., Puel J., Mirkovitch V., Joffre F., Kappenberger L., Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Eng J Med 1987; 316: 701-706.
3. Dangas GD., Claessen BE., Caixeta A., Sanidas EA., Mintz GS., Mehran R., In-stent restenosis in the drug- eluting stent era. J Am Coll Cardiol 2010: 56: 1897-1907.
4. Chen MS., John JM., Chew DP., Lee DS., Ellis SG., Bhatt DL., Bare metal stent restenosis is not a benign clinical entity. Am Heart J. 2006; 151: 1260-1264.
5. Bossi I., Klersy C., Black AJ. Et al., In-stent restenosis: long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty. J Am Coll Cardiol 2000; 35: 1569-1576.
6. Strikwerda S., Montauban van Swijindregt E., Foley DP., et al., Immediate and late outcome of excimer laser and balloon coronary angioplasty: a quantitative angiographic comparison based on matched lesions. J Am Coll Cardiol 1995; 26: 939-46.
7. Hehrlein C., DeVries JJ., Arab A., et al., Failure of a novel balloon - expandable gamma-emitting((103)Pd) stent to prevent edge effects. Circulation 2001;104: 2358-2362.
8. Albiero R., Adamian M., Kobayashi N., et al. Short and intermediate term results of (32)P radioactive beta-emitting stent implantation in patients with coronary artery disease: the Milan Dose-Response
Study. Circulation 2000; 101: 18-26.
9. Alfonso F., Perez-Vizcayno MJ., Dutary J., et al., Implantation of a drug-eluting stent with a different drug (switch straegy) in patients with drug-eluting stent restenosis. Results from a prospectivemulticenter study (RIBS III [ Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent]). J Am Coll Cardiol Intv 2012;5: 728-737.
10. Lemos PA., Hoye A., Goedhart D.,et al. Clinical, angiographic, and precodural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004; 109: 1366-1370.
11. Herdeg C., Oberhoff M., Baumbach A.,et al., Local paclitaxel delivery for the prevention of restenosis: biological efects and efficacy in vivo. L AM Coll Cardiol 2000: 35: 1969-1976.
12. Axel DI., Kunert W., Goggelmann C., et al., Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997; 96: 636-645.
13. Werk M., Langner S., Reinkensmeier B., et al. Inhibitation of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized lipot trial. Circulation 2008; 118: 1358-1365.
14. Scheller B., Hehrlein C., Bocksch W., et al. Treament of coronary in-stent restenosis with a paclitaxel- coated balloon catheter. N Engl J Med. 2006; 355: 2113-2124.
15. Habara S., Mitsudo K., Kadota K., et al., Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. J Am Coll Cardiol Intv 2011; 4: 149-154.
16. Rittger H., Brachmann J., Sinha AM., et al. A randomized, multicenter, single-blinede trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES sudy. J Am Coll Cardiol 2012; 59: 1377-1382.
17. Byrne RA., Neumann FJ., Mehilli J., et al., Paclitaxxel balloons, paclitaxel-eluting stents, and balloon angiplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet 2013; 381:461-467.
18. Indermuehle A., Bahl R., Lansky Ạ., et al. Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials. Heart 2013;99: 327-333.
19. Agostoni P., Belkacemi A., Voskuil M., Nathoe HM., Doevendans PA., Stella PR., Serial morphological and functional assessment of drug-eluting balloon for in-stent restenosis lesions: mechanisms of action evaluted with angioplasty, optical coherence tomography and fractional flow reserve. J Am Coll Cardiol Intv 2013; 6: 569-576.
20. Mehilli J., Byme RA., Tiroch K., et al. Randomized trial of paclitaxel versus sirolimus-eluting stents for treament of coronary restenosis in sirolimus-eluting stents: ISAR-DESIRE 2 ( Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. J Am Coll Cardiol 2010; 55: 2710-2716.
21. Wijins W., Kolh P., Danchin N., et al. Guidelines on myocardial revascularization. Eur Heart J 2010; 31: 2501-2555.
